Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry

被引:6
作者
Apiyasawat, Sirin [1 ]
Kornbongkotmas, Sakaorat [2 ]
Chichareon, Ply [3 ]
Krittayaphong, Rungroj [4 ]
机构
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand
[2] Queen Savang Vadhana Mem Hosp, Chon Buri, Thailand
[3] Prince Songkla Univ, Fac Med, Hat Yai, Thailand
[4] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand
关键词
atrial fibrillation; atrial fibrillation type; mortality; registry; stroke; FOLLOW-UP; PERSISTENT; PROGRESSION; STROKE; DEFINITION; PROGNOSIS; WARFARIN; DEATH;
D O I
10.1002/joa3.12643
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Persistent and permanent atrial fibrillation (AF) often occurs in the presence of multiple comorbidities and is linked to adverse outcomes. It is unclear whether the sustained pattern of AF itself is prognostic or if it is confounded by underlying comorbidities. Here, we tested the association between the temporal patterns of AF and the risks of ischemic stroke and all-cause mortality. Methods and Results: In a prospective multicenter cohort, 3046 non-valvular AF patients were consecutively enrolled and followed for adverse outcomes of all-cause mortality and ischemic stroke. The risks of both outcomes were adjusted for underlying comorbidities, and compared between the patterns of AF. At baseline, the patients were classified as paroxysmal (N = 963, 31.6%), persistent (N = 604, 19.8%), and permanent AF (N = 1479, 45.6%) according to the standard definition. Anticoagulants were administered in 75% of all patients and 83% of those with CHA(2)DS(2)-VAS(c) score >= 2 in males or >= 3 in females. During a mean follow up of 26 (SD 10.5) months, all-cause mortality occurred less in paroxysmal AF (2.5 per 100 patient-years) than in persistent AF (4.4 per 100 patient-years; adjusted hazard ratio [HR] 0.66, 95% CI, 0.46-0.96; P = .029) and permanent AF (4.1 per 100 patient-years; adjusted HR 0.71, 95% CI, 0.52-0.98; P = .036). The risk of ischemic stroke was similar across all patterns of AF. Conclusions: In this multicenter cohort of AF patients, persistent and permanent AF was associated with higher all-cause mortality than paroxysmal AF, independent of baseline comorbidities. Clinical Trial Registration Thai Clinical Trial Registration; Study ID: TCTR20160113002 ().
引用
收藏
页码:1434 / 1442
页数:9
相关论文
共 30 条
  • [1] The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
    Atar, Dan
    Berge, Eivind
    Le Heuzey, Jean-Yves
    Virdone, Saverio
    Camm, A. John
    Steffel, Jan
    Gibbs, Harry
    Goldhaber, Samuel Z.
    Goto, Shinya
    Kayani, Gloria
    Misselwitz, Frank
    Stepinska, Janina
    Turpie, Alexander G. G.
    Bassand, Jean-Pierre
    Kakkar, Ajay K.
    [J]. EUROPACE, 2020, 22 (02): : 195 - 204
  • [2] Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project
    Banerjee, Amitava
    Taillandier, Sophie
    Olesen, Jonas Bjerring
    Lane, Deirdre A.
    Lallemand, Benedicte
    Lip, Gregory Y. H.
    Fauchier, Laurent
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (06) : 2682 - 2687
  • [3] Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice Insight From the Real-Life Global Survey Evaluating Patients With Atrial Fibrillation International Registry
    Chiang, Chern-En
    Naditch-Brule, Lisa
    Murin, Jan
    Goethals, Marnix
    Inoue, Hiroshi
    O'Neill, James
    Silva-Cardoso, Jose
    Zharinov, Oleg
    Gamra, Habib
    Alam, Samir
    Ponikowski, Piotr
    Lewalter, Thorsten
    Rosenqvist, Marten
    Steg, Philippe Gabriel
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (04) : 632 - 639
  • [4] Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
    Haas, Sylvia
    ten Cate, Hugo
    Accetta, Gabriele
    Angchaisuksiri, Pantep
    Bassand, Jean-Pierre
    Camm, A. John
    Corbalan, Ramon
    Darius, Harald
    Fitzmaurice, David A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Jacobson, Barry
    Kayani, Gloria
    Mantovani, Lorenzo G.
    Misselwitz, Frank
    Pieper, Karen
    Schellong, Sebastian M.
    Stepinska, Janina
    Turpie, Alexander G. G.
    van Eickels, Martin
    Kakkar, Ajay K.
    Lucas Luciardi, Hector
    Gibbs, Harry
    Brodmann, Marianne
    Cools, Frank
    Pereira Barretto, Antonio Carlos
    Connolly, Stuart J.
    Spyropoulos, Alex
    Eikelboom, John
    Hu, Dayi
    Jansky, Petr
    Nielsen, Jorn Dalsgaard
    Ragy, Hany
    Raatikainen, Pekka
    Le Heuzey, Jean-Yves
    Keltai, Matyas
    Kakkar, Sanjay
    Sawhney, Jitendra Pal Singh
    Agnelli, Giancarlo
    Ambrosio, Giuseppe
    Koretsune, Yukihiro
    Sanchez Diaz, Carlos Jerjes
    Atar, Dan
    Panchenko, Elizaveta
    Lim, Toon Wei
    Oh, Seil
    Vinolas, Xavier
    Rosenqvist, Marten
    Steffel, Jan
    Oto, Ali
    [J]. PLOS ONE, 2016, 11 (10):
  • [5] Statistical primer: checking model assumptions with regression diagnostics
    Hickey, Graeme L.
    Kontopantelis, Evangelos
    Takkenberg, Johanna J. M.
    Beyersdorf, Friedhelm
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 28 (01) : 1 - 8
  • [7] Dabigatran Versus Warfarin Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation
    Hori, Masatsugu
    Connolly, Stuart J.
    Zhu, Jun
    Liu, Li Sheng
    Lau, Chu-Pak
    Pais, Prem
    Xavier, Denis
    Kim, Sung Soon
    Omar, Razali
    Dans, Antonio L.
    Tan, Ru San
    Chen, Jyh-Hong
    Tanomsup, Supachai
    Watanabe, Mitsunori
    Koyanagi, Masahide
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Wallentin, Lars
    Yusuf, Salim
    [J]. STROKE, 2013, 44 (07) : 1891 - +
  • [8] Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    [J]. CIRCULATION JOURNAL, 2012, 76 (09) : 2104 - 2111
  • [9] Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice
    Jachno, Kim
    Heritier, Stephane
    Wolfe, Rory
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (1)
  • [10] KANNEL WB, 1982, N ENGL J MED, V0306